A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma
Targeting the epidermal growth factor receptor (EGFR) is one of the potential ways to treat glioblastoma (GBM). In this study, we investigate the anti-GBM tumor effects of the EGFR inhibitor SMUZ106 in both in vitro and in vivo conditions. The effects of SMUZ106 on the growth and proliferation of GB...
Saved in:
Main Authors: | Ying Jiang (Author), Chunhui Huang (Author), Yaqi Huang (Author), Lifan Long (Author), Guowu Wu (Author), Fengqiu Guo (Author), Chuan Huang (Author), Siming Liu (Author), Zhengguang Zhu (Author), Shaoyu Wu (Author), Zhonghuang Li (Author), Jiajie Zhang (Author), Shanhe Wan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of novel 2-aminopyridine derivatives as ROS1 and ALK dual inhibitors to combat drug-resistant mutants including ROS1G2032R and ALKG1202R
by: Siming Liu, et al.
Published: (2023) -
Identification of imidazo[4,5-c]pyridin-2-one derivatives as novel Src family kinase inhibitors against glioblastoma
by: Lishun Zhang, et al.
Published: (2021) -
Immune Checkpoint in Glioblastoma: Promising and Challenging
by: Jing Huang, et al.
Published: (2017) -
Revisiting epidermal growth factor receptor in glioblastoma multiforme: Does it play a role in response to therapy?
by: Priyanka Soni, et al.
Published: (2014) -
Role of microRNAs in embryo implantation
by: Jingjie Liang, et al.
Published: (2017)